Modern Diagnostic And Treatment Methods For Chronic Hepatitis

Abstract

Chronic hepatitis is a significant global health concern, requiring advanced diagnostic and therapeutic approaches to improve patient outcomes. This study explores modern methods for diagnosing and treating chronic hepatitis, focusing on innovative laboratory, imaging, and molecular techniques. The introduction of non-invasive diagnostic tools such as transient elastography (FibroScan), magnetic resonance elastography (MRE), and serum biomarkers has enhanced early disease detection and monitoring of liver fibrosis.
         In terms of treatment, novel antiviral therapies including direct-acting antivirals (DAAs) for hepatitis C and immunomodulatory agents for hepatitis B have revolutionized management strategies, significantly improving viral suppression rates and reducing liver complications. Additionally, research into gene therapy and hepatocyte regeneration technologies holds promise for future treatment modalities. This study also highlights the role of personalized medicine in optimizing therapy based on genetic and immunological profiles. The integration of artificial intelligence (AI) and big data analytics in hepatology has
further enhanced diagnostic precision and treatment efficacy. The findings emphasize the need for a multidisciplinary approach that combines pharmacological, technological, and lifestyle interventions to improve long-term prognosis in patients with chronic hepatitis.